Benzydamin (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Benzydamin" in Swedish language version.

refsWebsite

Global rank Swedish rank

11nih.gov

4^th place

17^th place

7doi.org

2^nd place

14^th place

1diff.org

low place

1sussex.ac.uk

6,651^st place

6,860^th place

diff.org

flipper.diff.org

”DEXTROMETHORPHAN AND BENZYDAMINE'S USE AND MISUSE”. Flipper.diff.org. https://flipper.diff.org/app/items/info/6989.

doi.org

dx.doi.org

”Synthesis and pharmacological properties of 1-substituted 3-dimethylaminoalkoxy-1H-indazoles”. Journal of Medicinal Chemistry 9 (1): sid. 38–41. January 1966. doi:10.1021/jm00319a009. PMID 5958958.
”Recreational abuse with benzydamine hydrochloride (tantum rosa)”. Clinical Toxicology 45 (2): sid. 198–9. 2007. doi:10.1080/15563650600981210. PMID 17364645.
”Recreational use of benzydamine as a hallucinogen among street youth in Brazil”. Revista Brasileira de Psiquiatria 31 (3): sid. 208–13. September 2009. doi:10.1590/S1516-44462009000300005. PMID 19784487.
”Use abusive of benzydamine in Brazil: an overview in pharmacovigilance” (på portugisiska). Ciencia & Saude Coletiva 15 (3): sid. 717–24. May 2010. doi:10.1590/S1413-81232010000300014. PMID 20464184.
”Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action”. Addiction Biology 23 (2): sid. 610–619. March 2018. doi:10.1111/adb.12516. PMID 28429885. http://sro.sussex.ac.uk/id/eprint/67500/1/__smbhome.uscs.susx.ac.uk_ellenaj_Desktop_SRO_Avvisati_BZY_R2.pdf.
”Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects”. Biopharmaceutics & Drug Disposition 12 (7): sid. 481–92. October 1991. doi:10.1002/bdd.2510120702. PMID 1932611.
”Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent”. Journal of Chemotherapy 4 (6): sid. 347–52. December 1992. doi:10.1080/1120009X.1992.11739190. PMID 1287137.

nih.gov

ncbi.nlm.nih.gov

”Benzydamine Hydrochloride (Tantum) in the management of oral inflammatory conditions”. Journal 61 (2): sid. 127–34. February 1995. PMID 7600413.
”Synthesis and pharmacological properties of 1-substituted 3-dimethylaminoalkoxy-1H-indazoles”. Journal of Medicinal Chemistry 9 (1): sid. 38–41. January 1966. doi:10.1021/jm00319a009. PMID 5958958.
”Recreational abuse with benzydamine hydrochloride (tantum rosa)”. Clinical Toxicology 45 (2): sid. 198–9. 2007. doi:10.1080/15563650600981210. PMID 17364645.
”Recreational use of benzydamine as a hallucinogen among street youth in Brazil”. Revista Brasileira de Psiquiatria 31 (3): sid. 208–13. September 2009. doi:10.1590/S1516-44462009000300005. PMID 19784487.
”Use abusive of benzydamine in Brazil: an overview in pharmacovigilance” (på portugisiska). Ciencia & Saude Coletiva 15 (3): sid. 717–24. May 2010. doi:10.1590/S1413-81232010000300014. PMID 20464184.
”New pharmacologic and biochemical findings on the mechanism of action of the non-steroidal antiphlogistic, benzydamine. A synopsis” (på German). Arzneimittel-Forschung 37 (5A): sid. 635–45. May 1987. PMID 3304305.
”Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action”. Addiction Biology 23 (2): sid. 610–619. March 2018. doi:10.1111/adb.12516. PMID 28429885. http://sro.sussex.ac.uk/id/eprint/67500/1/__smbhome.uscs.susx.ac.uk_ellenaj_Desktop_SRO_Avvisati_BZY_R2.pdf.
”Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects”. Biopharmaceutics & Drug Disposition 12 (7): sid. 481–92. October 1991. doi:10.1002/bdd.2510120702. PMID 1932611.
”Concentration of benzydamine in vaginal mucosa following local application: an experimental and clinical study”. International Journal of Tissue Reactions 9 (2): sid. 135–45. 1987. PMID 3610512.
”Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent”. Journal of Chemotherapy 4 (6): sid. 347–52. December 1992. doi:10.1080/1120009X.1992.11739190. PMID 1287137.
”Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates”. Arzneimittel-Forschung 46 (3): sid. 320–3. March 1996. PMID 8901158.

sussex.ac.uk

sro.sussex.ac.uk

”Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action”. Addiction Biology 23 (2): sid. 610–619. March 2018. doi:10.1111/adb.12516. PMID 28429885. http://sro.sussex.ac.uk/id/eprint/67500/1/__smbhome.uscs.susx.ac.uk_ellenaj_Desktop_SRO_Avvisati_BZY_R2.pdf.